Amicus Therapeutics
Why Robinhood?
You can watch FOLD and buy or sell other stocks, ETFs, and their options commission-free!About FOLD
Amicus Therapeutics is a biotechnology company that focuses on discovering, developing, and commercializing medicines for rare and genetic diseases. It develops and delivers treatment programs, including oral therapies and combination regimens for specific metabolic conditions such as Fabry and Pompe diseases, and it manages research and licensing activities for additional potential therapies like treatments for focal segmental glomerulosclerosis.
FOLD Key Statistics
Stock Snapshot
With a market cap of 4.5B, Amicus Therapeutics(FOLD) trades at $14.49. The stock has a price-to-earnings ratio of -163.54.
During the trading day, Amicus Therapeutics(FOLD) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Amicus Therapeutics(FOLD) stock has reached 0, versus its average volume of 1.43M.
The stock's 52-week range extends from a low of $5.52 to a high of $14.50.
The stock's 52-week range extends from a low of $5.52 to a high of $14.50.
FOLD News
BioMarin Pharmaceutical has completed its acquisition of Amicus Therapeutics, previously listed as NasdaqGM:FOLD. Following the transaction, Amicus has been de...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.